R&D Systems™ Recombinant Human LRIT2 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human LRIT2 Protein is derived from CHO. The Recombinant Human LRIT2 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: A6NDA9
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS
• Gene ID (Entrez): 340745
• Molecular Weight (g/mol): 49kDa
• Name: LRIT2
• Preparation Method: Reconstitute at 500μg/mL in PBS.
• Quality Control Testing: SDS-PAGE: 67-81kDa, reducing conditions
• Quantity: 50μg
• Source: Chinese Hamster Ovary cell line,CHO-derived human LRIT2 protein Gln21-His462 (Leu220Phe) with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: Gln21
• Without Additives: Carrier Protein
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE with silver staining